The role of [18F]FDG PET/CT for gastric cancer management.

IF 0.6 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

NUCLEAR MEDICINE REVIEW Pub Date : 2021-01-01 DOI:10.5603/NMR.2021.0021

Ebru Salmanoglu

引用次数: 2

Abstract

Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient's clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [¹⁸F]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [¹⁸F]FDG PET/CT for GC management.

查看原文本刊更多论文

[18F]FDG PET/CT在胃癌治疗中的作用。

胃癌(GC)是世界上癌症相关死亡的常见原因。除了患者的临床病史和临床检查外，诊断还需要核医学工具。[¹⁸F]FDG PET/CT已广泛用于癌症患者的分期、再分期和治疗反应评估。本研究旨在回顾[¹⁸F]FDG PET/CT在气相色谱管理中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NUCLEAR MEDICINE REVIEW RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

24 weeks

期刊介绍： Written in English, NMR is a biannual international periodical of scientific and educational profile. It is a journal of Bulgarian, Czech, Hungarian, Macedonian, Polish, Romanian, Russian, Slovak, Ukrainian and Yugoslav Societies of Nuclear Medicine. The periodical focuses on all nuclear medicine topics (diagnostics as well as therapy), and presents original experimental scientific papers, reviews, case studies, letters also news about symposia and congresses. NMR is indexed at Index Copernicus (7.41), Scopus, EMBASE, Index Medicus/Medline, Ministry of Education 2007 (4 pts.).